Diagnostic Medical Systems (0RIA) Ratios
Diagnostic Medical Systems Ratios
GB:0RIA's free cash flow for Q2 2026 was $-3.80M. For the 2026 fiscal year, GB:0RIA's free cash flow was decreased by $-1.29M and operating cash flow was $-2.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.37 | 1.29 | 1.44 | 1.19 | 1.29 |
| Quick Ratio | 0.81 | 0.67 | 0.71 | 0.65 | 0.75 |
| Cash Ratio | 0.26 | 0.23 | 0.22 | 0.18 | 0.19 |
| Solvency Ratio | 0.05 | 0.00 | -0.07 | -0.13 | -0.06 |
| Operating Cash Flow Ratio | -0.01 | 0.15 | -0.07 | 0.04 | -0.05 |
| Short-Term Operating Cash Flow Coverage | -0.03 | 0.46 | -0.26 | 0.22 | -0.21 |
| Net Current Asset Value | $ -3.90M | $ -9.49M | $ -5.74M | $ -6.74M | $ -4.53M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.37 | 0.39 | 0.29 | 0.30 |
| Debt-to-Equity Ratio | 0.98 | 1.56 | 1.62 | 0.98 | 0.85 |
| Debt-to-Capital Ratio | 0.49 | 0.61 | 0.62 | 0.50 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.26 | 0.38 | 0.43 | 0.28 | 0.22 |
| Financial Leverage Ratio | 3.27 | 4.20 | 4.13 | 3.44 | 2.83 |
| Debt Service Coverage Ratio | 0.41 | -0.04 | 0.12 | -0.94 | -0.10 |
| Interest Coverage Ratio | 1.68 | -0.15 | -4.97 | -26.11 | -2.18 |
| Debt to Market Cap | 0.46 | 1.17 | 0.78 | 0.65 | 0.53 |
| Interest Debt Per Share | 0.74 | 1.24 | 1.17 | 0.97 | 1.01 |
| Net Debt to EBITDA | 2.75 | -73.67 | 18.42 | -2.57 | -32.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 3.34% | 39.92% | 36.30% | 39.22% | 38.28% |
| EBIT Margin | 3.70% | -6.73% | -3.32% | -18.20% | -6.33% |
| EBITDA Margin | 8.42% | -0.43% | 1.88% | -12.13% | -1.00% |
| Operating Profit Margin | 3.70% | -0.75% | -5.13% | -16.66% | -2.30% |
| Pretax Profit Margin | 0.24% | -5.67% | -22.29% | -18.82% | -7.64% |
| Net Profit Margin | -0.33% | -6.25% | -11.21% | -19.34% | -10.68% |
| Continuous Operations Profit Margin | 0.10% | -6.11% | -22.30% | -18.88% | -7.64% |
| Net Income Per EBT | -136.89% | 110.30% | 50.29% | 102.73% | 139.84% |
| EBT Per EBIT | 6.60% | 754.62% | 434.17% | 113.00% | 332.25% |
| Return on Assets (ROA) | -0.27% | -5.34% | -9.67% | -12.65% | -7.31% |
| Return on Equity (ROE) | -0.87% | -22.44% | -39.94% | -43.55% | -20.69% |
| Return on Capital Employed (ROCE) | 5.30% | -1.14% | -7.78% | -19.93% | -2.66% |
| Return on Invested Capital (ROIC) | 1.66% | -0.89% | -6.29% | -24.04% | -2.37% |
| Return on Tangible Assets | -0.39% | -8.18% | -13.24% | -14.76% | -9.67% |
| Earnings Yield | -0.49% | -21.21% | -24.84% | -41.89% | -19.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.82 | 5.23 | 5.09 | 3.56 | 3.23 |
| Payables Turnover | 3.44 | 2.55 | 2.70 | 1.94 | 2.38 |
| Inventory Turnover | 3.08 | 1.92 | 1.75 | 1.64 | 1.94 |
| Fixed Asset Turnover | 12.64 | 10.21 | 8.61 | 6.41 | 5.98 |
| Asset Turnover | 0.80 | 0.85 | 0.86 | 0.65 | 0.68 |
| Working Capital Turnover Ratio | 5.84 | 5.60 | 6.20 | 6.44 | 5.70 |
| Cash Conversion Cycle | 108.04 | 117.31 | 144.88 | 136.86 | 147.40 |
| Days of Sales Outstanding | 95.54 | 69.86 | 71.71 | 102.67 | 113.01 |
| Days of Inventory Outstanding | 118.51 | 190.54 | 208.32 | 222.18 | 188.02 |
| Days of Payables Outstanding | 106.01 | 143.09 | 135.15 | 187.99 | 153.63 |
| Operating Cycle | 214.05 | 260.39 | 280.03 | 324.85 | 301.03 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | 0.20 | -0.09 | 0.06 | -0.07 |
| Free Cash Flow Per Share | -0.12 | 0.00 | -0.25 | -0.10 | -0.43 |
| Dividend Paid and CapEx Coverage Ratio | -0.09 | 1.01 | -0.60 | 0.37 | -0.18 |
| Capital Expenditure Coverage Ratio | -0.09 | 1.01 | -0.60 | 0.37 | -0.18 |
| Operating Cash Flow Coverage Ratio | -0.01 | 0.18 | -0.08 | 0.06 | -0.07 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.08 | -0.04 | 0.03 | -0.03 |
| Free Cash Flow Yield | -9.36% | 0.22% | -21.95% | -10.04% | -35.41% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -186.76 | -4.71 | -4.03 | -2.39 | -5.08 |
| Price-to-Sales (P/S) Ratio | 0.68 | 0.29 | 0.45 | 0.46 | 0.54 |
| Price-to-Book (P/B) Ratio | 1.77 | 1.06 | 1.61 | 1.04 | 1.05 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.68 | 452.56 | -4.56 | -9.96 | -2.82 |
| Price-to-Operating Cash Flow Ratio | -133.33 | 3.77 | -12.10 | 16.96 | -18.16 |
| Price-to-Earnings Growth (PEG) Ratio | 1.95 | 0.07 | -0.12 | -0.03 | 0.20 |
| Enterprise Value Multiple | 10.80 | -141.55 | 42.37 | -6.37 | -86.08 |
| Enterprise Value | 45.45M | 28.31M | 35.21M | 27.26M | 31.33M |
| EV to EBITDA | 10.80 | -141.55 | 42.37 | -6.37 | -86.08 |
| EV to Sales | 0.91 | 0.61 | 0.80 | 0.77 | 0.86 |
| EV to Free Cash Flow | -14.34 | 943.69 | -8.06 | -16.67 | -4.50 |
| EV to Operating Cash Flow | -178.95 | 7.86 | -21.41 | 28.40 | -28.93 |
| Tangible Book Value Per Share | 0.02 | -0.25 | -0.00 | 0.65 | 0.46 |
| Shareholders’ Equity Per Share | 0.72 | 0.71 | 0.71 | 0.97 | 1.16 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.61 | -0.08 | -0.00 | -0.00 | -0.06 |
| Revenue Per Share | 1.87 | 2.54 | 2.53 | 2.19 | 2.25 |
| Net Income Per Share | -0.01 | -0.16 | -0.28 | -0.42 | -0.24 |
| Tax Burden | -1.37 | 1.10 | 0.50 | 1.03 | 1.40 |
| Interest Burden | 0.07 | 0.84 | 6.71 | 1.03 | 1.21 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.05 | 0.06 | 0.09 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.52 | -1.28 | 0.33 | -0.11 | 0.23 |
Currency in EUR